July Drug Product Recalls Feature Teva, Advantage Dose Cases
This article was originally published in The Gold Sheet
Executive Summary
July drug recalls feature concerns about endotoxins that FDA raised with Teva. Meanwhile, the Advantage Dose recall reports continued to roll in by the hundreds.